Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction

Aim. To study the efficacy of use of amiodarone with ivabradine combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation (AF) recurrence in patients (pts) with left ventricular diastolic dysfunction (LVDD) after conversion to sinus rhythm. Material and methods....

Full description

Bibliographic Details
Main Authors: K. G. Adamyan, L. G. Tunyan, A. L. Chilingaryan
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
Online Access:https://www.rpcardio.com/jour/article/view/321
id doaj-0611996552af4ef59947326bf35e52a4
record_format Article
spelling doaj-0611996552af4ef59947326bf35e52a42021-09-03T13:15:14ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-11-0111548348810.20996/1819-6446-2015-11-5-483-488321Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunctionK. G. Adamyan0L. G. Tunyan1A. L. Chilingaryan2Research Institute of Cardiology. P. Sevak str. 5, Erevan 0044, Republic of ArmeniaResearch Institute of Cardiology. P. Sevak str. 5, Erevan 0044, Republic of ArmeniaResearch Institute of Cardiology. P. Sevak str. 5, Erevan 0044, Republic of ArmeniaAim. To study the efficacy of use of amiodarone with ivabradine combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation (AF) recurrence in patients (pts) with left ventricular diastolic dysfunction (LVDD) after conversion to sinus rhythm. Material and methods. 65 patients (40 males, 25 females) aged 53±8 years with persistent AF and LVDD were included into the study and randomized into 3 groups to receive ivabradine and amiodarone (22 pts), bisoprolol and amiodarone (22 pts) or amiodarone alone (21 pts). Left atrium (LA) volume indices, LA longitudinal strain rate (LASR) in systole, LV mass index, mean heart rate (HR), 24-hour HR variability and the incidence of AF by 96 h ECG monitoring were measured after the titration period, and after 3 and 6 months of follow-up. Results. After 6 months of follow-up group 1 revealed significantly lower maximum LA volume index (21.3±2.4 vs 25.2±3.0 and 28.7±3.6 ml/m2 in the 2nd and control groups, respectively), P-wave LA volume index (15.3±3.5 versus 18.1±3.8 and 20.4±4.0 ml/m2 in the 2nd and control groups, respectively), and LA systolic volume index (7.3±1.2 versus 9.4±1.6 and 9.6±1.7 ml/m2 in 2nd and control groups, respectively). The incidence of side effects in group 1 was significantly less than that in group 2 and was not different compared with control group. Conclusion. Ivabradine and amiodarone combination provides better prevention of AF recurrence and less side-effects in pts with LVDD and persistent AF after sinus rhythm restoration as compared with bisoprolol and amiodarone combination, it also reduces LA maximum, conduit and systolic volumes, and increases LASR.https://www.rpcardio.com/jour/article/view/321diastolic dysfunctionivabradinebisoprololamiodaroneatrial fibrillation
collection DOAJ
language English
format Article
sources DOAJ
author K. G. Adamyan
L. G. Tunyan
A. L. Chilingaryan
spellingShingle K. G. Adamyan
L. G. Tunyan
A. L. Chilingaryan
Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
Racionalʹnaâ Farmakoterapiâ v Kardiologii
diastolic dysfunction
ivabradine
bisoprolol
amiodarone
atrial fibrillation
author_facet K. G. Adamyan
L. G. Tunyan
A. L. Chilingaryan
author_sort K. G. Adamyan
title Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
title_short Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
title_full Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
title_fullStr Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
title_full_unstemmed Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
title_sort comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-11-01
description Aim. To study the efficacy of use of amiodarone with ivabradine combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation (AF) recurrence in patients (pts) with left ventricular diastolic dysfunction (LVDD) after conversion to sinus rhythm. Material and methods. 65 patients (40 males, 25 females) aged 53±8 years with persistent AF and LVDD were included into the study and randomized into 3 groups to receive ivabradine and amiodarone (22 pts), bisoprolol and amiodarone (22 pts) or amiodarone alone (21 pts). Left atrium (LA) volume indices, LA longitudinal strain rate (LASR) in systole, LV mass index, mean heart rate (HR), 24-hour HR variability and the incidence of AF by 96 h ECG monitoring were measured after the titration period, and after 3 and 6 months of follow-up. Results. After 6 months of follow-up group 1 revealed significantly lower maximum LA volume index (21.3±2.4 vs 25.2±3.0 and 28.7±3.6 ml/m2 in the 2nd and control groups, respectively), P-wave LA volume index (15.3±3.5 versus 18.1±3.8 and 20.4±4.0 ml/m2 in the 2nd and control groups, respectively), and LA systolic volume index (7.3±1.2 versus 9.4±1.6 and 9.6±1.7 ml/m2 in 2nd and control groups, respectively). The incidence of side effects in group 1 was significantly less than that in group 2 and was not different compared with control group. Conclusion. Ivabradine and amiodarone combination provides better prevention of AF recurrence and less side-effects in pts with LVDD and persistent AF after sinus rhythm restoration as compared with bisoprolol and amiodarone combination, it also reduces LA maximum, conduit and systolic volumes, and increases LASR.
topic diastolic dysfunction
ivabradine
bisoprolol
amiodarone
atrial fibrillation
url https://www.rpcardio.com/jour/article/view/321
work_keys_str_mv AT kgadamyan comparativeefficacyofamiodaronewithivabradincombinationoramiodaronewithbisoprololcombinationinthepreventionofatrialfibrillationrecurrenceinpatientswithleftventriculardiastolicdysfunction
AT lgtunyan comparativeefficacyofamiodaronewithivabradincombinationoramiodaronewithbisoprololcombinationinthepreventionofatrialfibrillationrecurrenceinpatientswithleftventriculardiastolicdysfunction
AT alchilingaryan comparativeefficacyofamiodaronewithivabradincombinationoramiodaronewithbisoprololcombinationinthepreventionofatrialfibrillationrecurrenceinpatientswithleftventriculardiastolicdysfunction
_version_ 1717817011034128384